West Pharmaceutical Services ROE 2010-2024 | WST
Current and historical return on equity (ROE) values for West Pharmaceutical Services (WST) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| West Pharmaceutical Services ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-09-30 |
$0.50B |
$2.75B |
18.33% |
| 2024-06-30 |
$0.52B |
$2.58B |
19.04% |
| 2024-03-31 |
$0.57B |
$2.68B |
20.33% |
| 2023-12-31 |
$0.59B |
$2.88B |
21.04% |
| 2023-09-30 |
$0.56B |
$2.87B |
20.19% |
| 2023-06-30 |
$0.52B |
$2.75B |
19.44% |
| 2023-03-31 |
$0.55B |
$2.78B |
21.36% |
| 2022-12-31 |
$0.59B |
$2.69B |
23.70% |
| 2022-09-30 |
$0.63B |
$2.47B |
26.45% |
| 2022-06-30 |
$0.69B |
$2.42B |
29.59% |
| 2022-03-31 |
$0.69B |
$2.33B |
30.80% |
| 2021-12-31 |
$0.66B |
$2.34B |
31.53% |
| 2021-09-30 |
$0.61B |
$2.20B |
30.91% |
| 2021-06-30 |
$0.52B |
$2.03B |
27.86% |
| 2021-03-31 |
$0.42B |
$1.83B |
24.08% |
| 2020-12-31 |
$0.35B |
$1.86B |
20.69% |
| 2020-09-30 |
$0.31B |
$1.72B |
19.47% |
| 2020-06-30 |
$0.29B |
$1.61B |
18.52% |
| 2020-03-31 |
$0.26B |
$1.49B |
17.34% |
| 2019-12-31 |
$0.24B |
$1.57B |
16.41% |
| 2019-09-30 |
$0.23B |
$1.49B |
16.07% |
| 2019-06-30 |
$0.23B |
$1.45B |
16.39% |
| 2019-03-31 |
$0.22B |
$1.37B |
16.15% |
| 2018-12-31 |
$0.21B |
$1.40B |
15.52% |
| 2018-09-30 |
$0.16B |
$1.35B |
11.88% |
| 2018-06-30 |
$0.15B |
$1.28B |
11.65% |
| 2018-03-31 |
$0.13B |
$1.31B |
10.42% |
| 2017-12-31 |
$0.15B |
$1.28B |
12.06% |
| 2017-09-30 |
$0.19B |
$1.32B |
15.68% |
| 2017-06-30 |
$0.18B |
$1.24B |
15.16% |
| 2017-03-31 |
$0.18B |
$1.17B |
16.13% |
| 2016-12-31 |
$0.14B |
$1.12B |
12.96% |
| 2016-09-30 |
$0.14B |
$1.14B |
12.69% |
| 2016-06-30 |
$0.10B |
$1.11B |
9.71% |
| 2016-03-31 |
$0.09B |
$1.07B |
8.33% |
| 2015-12-31 |
$0.10B |
$1.02B |
9.72% |
| 2015-09-30 |
$0.09B |
$1.00B |
9.69% |
| 2015-06-30 |
$0.12B |
$0.99B |
12.76% |
| 2015-03-31 |
$0.13B |
$0.94B |
13.85% |
| 2014-12-31 |
$0.13B |
$0.96B |
13.25% |
| 2014-09-30 |
$0.12B |
$0.97B |
12.68% |
| 2014-06-30 |
$0.12B |
$0.97B |
12.71% |
| 2014-03-31 |
$0.11B |
$0.94B |
12.48% |
| 2013-12-31 |
$0.11B |
$0.91B |
13.81% |
| 2013-09-30 |
$0.11B |
$0.84B |
14.21% |
| 2013-06-30 |
$0.10B |
$0.78B |
13.17% |
| 2013-03-31 |
$0.08B |
$0.75B |
11.70% |
| 2012-12-31 |
$0.08B |
$0.73B |
11.49% |
| 2012-09-30 |
$0.08B |
$0.72B |
11.50% |
| 2012-06-30 |
$0.08B |
$0.68B |
11.91% |
| 2012-03-31 |
$0.09B |
$0.70B |
12.42% |
| 2011-12-31 |
$0.08B |
$0.66B |
11.24% |
| 2011-09-30 |
$0.06B |
$0.69B |
9.42% |
| 2011-06-30 |
$0.06B |
$0.70B |
9.78% |
| 2011-03-31 |
$0.07B |
$0.66B |
10.59% |
| 2010-12-31 |
$0.07B |
$0.63B |
10.96% |
| 2010-09-30 |
$0.08B |
$0.63B |
13.55% |
| 2010-06-30 |
$0.08B |
$0.57B |
13.76% |
| 2010-03-31 |
$0.08B |
$0.58B |
13.64% |
| 2009-12-31 |
$0.07B |
$0.58B |
13.29% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$22.024B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
